The prefilled syringe fill / finish services market is projected to grow at an annualized rate of over 10%, till 2030
Roots Analysis has done a detailedstudy on Prefilled Syringe Fill / Finish Services Market, 2020-2030, covering key aspects of the industry’sevolution and identifying potential future growth opportunities.
To order this 260+page report, which features 60+ figures and 110+ tables, please visit this https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html
Key Market Insights
§ Over 100 companiesacross the globe claim to provide contract fill / finish services for prefilledsyringes; close to 50% of these service providers are large companies with over500 employees.
§ The market landscapefeatures the presence of well- established players in the domain, most of whichclaim to operate at various scales of operation and are located in differentgeographies.
§ In order to acquirecompetencies across the supply chain and cater to the evolving needs ofclients, companies offering services across different scales of operation haveestablished presence in various geographies.
§ Fill / finish serviceproviders are actively investing in expansion projects to upgrade existingcapabilities and capacity; several partnerships, mostly focused on offeringcontract services, have also been forged.
§ As expected, majorityof the installed contract fill / finish capacity for prefilled syringes belongsto the large service providers, accounting for around 80% of the availableglobal capacity.
§ The demand for fill /finish services for prefilled syringes is likely to steadily increase in thecoming years; we believe stakeholders may have to expand their respectivecapacities to ensure a consistent supply.
§ An evaluation ofprefilled syringe combination product developers revealed that Europe and NorthAmerica have emerged as the key regions for partnering opportunities for fill /finish service providers.
§ Caste Study: Around70 prefilled syringes are being manufactured by large companies, most of which claim to be capable of fabricatingsyringe barrels from both glass and plastic materials.
§ We expect drugdevelopers to continue to outsource their fill / finish operations in the shortto mid term, resulting in an annualized growth at the rate of over 8% withinthe contract services market.
§ In the long-term, theprojected opportunity for the fill / finish service providers for prefilledsyringes is likely to be well distributed across various types of barrelchambers, scales of operation and geographical regions.
For more information, please visit https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html
Table of Contents
1. PREFACE
1.1. Chapter Overview
1.2. Scope ofthe Report
1.3. ResearchMethodology
1.4. ChapterOutlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. ChapterOverview
3.2. Introductionto Prefilled Syringes
3.2.1. Classificationof Prefilled Syringes
3.2.2. Manufacturingof Prefilled Syringes
3.2.3. Advantagesof Prefilled Syringes
3.2.3.1. Benefits toHealthcare Professionals and End Users
3.2.3.2. Benefits toManufacturers
3.3. Fill /Finish Processing of Prefilled Syringes
3.3.1. StepsInvolved in Fill / Finish Process
3.3.2. Methods ofFilling and Stoppering of Prefilled Syringes
3.3.3. PrefilledSyringe Filling Technologies
3.4. FactorsContributing to the Growth of Prefilled Syringe Fill / Finish Market
3.5. Need forOutsourcing Fill / Finish Operations of Sterile Injectables
3.6. Advantagesof Outsourcing Fill / Finish Services
3.7. RisksAssociated with Outsourcing of Fill / Finish Operations
3.8. KeyConsiderations While Selecting a Fill / Finish Service Provider
4. MARKETLANDSCAPE
4.1. ChapterOverview
4.2. PrefilledSyringe Fill / Finish Service Providers: Overall Market Landscape
4.2.1. Analysis byYear of Establishment
4.2.2. Analysis byCompany Size
4.2.3. Analysis byScale of Operation
4.2.4. Analysis byLocation of Headquarters
4.2.5. Analysis byLocation of Prefilled Syringe Fill / Finish Facilities
4.2.6. Analysis byType of Drug Molecule
4.2.7. Analysis bySyringe Barrel Material
4.2.8. Analysis bySyringe Fill Volume
4.2.9. Analysis by AdditionalServices Offered
4.2.10. Heat Map:Analysis by Company Size and Location of Headquarters
4.2.11. LogoLandscape: Analysis by Company Size and Type of Drug Molecule
4.2.12. GeographicalMap: Analysis by Scale of Operation and Location of Fill / Finish Facilities
4.2.13. GridRepresentation: Distribution by Year of Establishment, Company Size and Type ofDrug Molecule
5. PREFILLEDSYRINGE FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES
5.1. ChapterOverview
5.2. AjinomotoBio-Pharma Services
5.2.1. Company Overview
5.2.2. RecentDevelopments and Future Outlook
5.3. AMRI
5.3.1. Company Overview
5.3.2. RecentDevelopments and Future Outlook
5.4. BioPharmaSolutions
5.4.1. Company Overview
5.4.2. RecentDevelopments and Future Outlook
5.5. EmergentBioSolutions
5.5.1. Company Overview
5.5.2. RecentDevelopments and Future Outlook
5.6. Patheon(a Thermo Fisher Scientific Company)
5.6.1. Company Overview
5.6.2. RecentDevelopments and Future Outlook
6. PREFILLED SYRINGEFILL / FINISH SERVICE PROVIDERS IN EUROPE: COMPANY PROFILES
6.1. ChapterOverview
6.2. ConsortMedical
6.2.1. Company Overview
6.2.2. RecentDevelopments and Future Outlook
6.3. EVER Pharma
6.3.1. Company Overview
6.3.2. RecentDevelopments and Future Outlook
6.4. GlaxoSmithKline
6.4.1. Company Overview
6.4.2. RecentDevelopments and Future Outlook
6.5. IDTBiologika
6.5.1. Company Overview
6.5.2. RecentDevelopments and Future Outlook
6.6. RentschlerBiopharma
6.6.1. Company Overview
6.6.2. RecentDevelopments and Future Outlook
6.7. Siegfried
6.7.1. Company Overview
6.7.2. RecentDevelopments and Future Outlook
6.8. VetterPharma
6.8.1. Company Overview
6.8.2. RecentDevelopments and Future Outlook
7. PREFILLEDSYRINGE FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC: COMPANY PROFILES
7.1. ChapterOverview
7.2. Biocon
7.2.1. Company Overview
7.2.2. RecentDevelopments and Future Outlook
7.3. IntasPharmaceuticals
7.3.1. Company Overview
7.3.2. RecentDevelopments and Future Outlook
7.4. KemwellBiopharma
7.4.1. Company Overview
7.4.2. RecentDevelopments and Future Outlook
7.5. SquarePharmaceuticals
7.5.1. Company Overview
7.5.2. RecentDevelopments and Future Outlook
8. PREFILLEDSYRINGE FILL / FINISH SERVICE PROVIDERS: RECENT DEVELOPMENTS
8.1. ChapterOverview
8.2. List ofExpansions
8.2.1. Analysis byYear of Expansion
8.2.2. Analysis byType of Expansion
8.2.3. Analysis byExpanded Scale of Operation
8.2.4. Analysis byLocation of Expansion Project
8.2.5. Analysis byType of Drug Molecule Involved
8.2.6. Analysis byAdditional Services Offered (Expansion Specific)
8.3. PartnershipModels
8.4. List ofPartnerships and Collaborations
8.4.1. Analysis byYear of Partnership
8.4.2. Analysis byType of Partnership
8.4.3. Analysis byScale of Operation (Deal Specific)
8.4.4. Analysis byAdditional Services Offered (Deal Specific)
9. CAPACITYANALYSIS
9.1. ChapterOverview
9.2. Assumptionsand Methodology
9.3. Global,Prefilled Syringe Fill / Finish Capacity (by Number of Units)
9.3.1. Analysis byCompany Size
9.3.2. Analysis byScale of Operation
9.3.3. Analysis byLocation of Headquarters
9.3.4. Analysis byLocation of Fill / Finish Facilities
9.3.5. Analysis byType of Drug Molecule
9.4. Global, PrefilledSyringe Fill / Finish Capacity (by Volume)
9.4.1. Analysis byCompany Size (Manufacturer)
9.4.2. Analysis byScale of Operation
9.4.3. Analysis byLocation of Headquarters
9.4.4. Analysis byLocation of Fill / Finish Facilities
9.4.5. Analysis by Typeof Drug Molecule
10. DEMANDANALYSIS
10.1. ChapterOverview
10.2. Assumptionsand Methodology
10.3. GlobalDemand for Prefilled Syringes Fill / Finish Services
10.3.1. Global Demandfor Commercialized Prefilled Syringes Fill / Finish Services
10.3.1.1. Analysis by Geography
10.3.1.1.1. North America
10.3.1.1.2. Europe
10.3.1.1.3. Asia-Pacific
10.3.1.1.4. Latin America
10.3.1.1.5. Middle East and Africa
10.3.1.2. Analysis by Syringe Barrel Material
10.3.1.3. Analysis by Number of Barrel Chambers
10.3.1.4. Analysis by Type of Drug Molecule
10.3.1.5. Analysis by Therapeutic Area
10.3.1.6. Analysis by Specialty Syringes
10.3.2. Global Demandfor Clinical Prefilled Syringes Fill / Finish Services
10.4. Demand andSupply Analysis
10.4.1. Demand andSupply Analysis (Scenario 1)
10.4.2. Demand andSupply Analysis (Scenario 2)
10.4.3. Demand andSupply Analysis (Scenario 3)
11. GEOGRAPHICALASSESSMENT OF DEMAND AND SUPPLY
11.1. ChapterOverview
11.2. Assumptionsand Key Parameters
11.3. Demand andSupply Assessment in North America
11.3.1. KeyGeographies
11.3.1.1. US
11.4. Demand andSupply Assessment in Europe
11.4.1. KeyGeographies
11.4.1.1. France
11.4.1.2. Germany
11.4.1.3. Italy
11.5. Demand andSupply Assessment in Asia-Pacific Region
11.5.1. KeyGeographies
11.5.1.1. India
11.5.1.2. Japan
12. LIKELYPARTNER ANALYSIS
12.1. ChapterOverview
12.2. Methodologyand Key Parameters
12.3. LikelyPartner Analysis
12.3.1. Opportunitiesin North America
12.3.1.1. Most Likely Partners for Prefilled Syringe Fill /Finish Service Providers
12.3.1.2. Likely Partners for Prefilled Syringe Fill /Finish Service Providers
12.3.2. Opportunitiesin Europe
12.3.2.1. Most Likely Partners for Prefilled Syringe Fill /Finish Service Providers
12.3.2.2. Likely Partners for Prefilled Syringe Fill /Finish Service Providers
12.3.3. Opportunitiesin Asia-Pacific and Rest of the World
12.3.3.1. Most Likely Partners for Prefilled Syringe Fill /Finish Service Providers
12.3.3.2. Likely Partners for Prefilled Syringe Fill /Finish Service Providers
13. MARKETSIZING AND OPPORTUNITY ANALYSIS
13.1. ChapterOverview
13.2. ForecastMethodology and Key Assumptions
13.3. OverallPrefilled Syringe Fill / Finish Services Market, 2020-2030
13.3.1. PrefilledSyringe Fill / Finish Services Market: Distribution by Scale of Operation,2020-2030
13.3.2. PrefilledSyringe Fill / Finish Services Market: Distribution by Geographical Region
13.3.2.1. Prefilled Syringe Fill / Finish Services Marketin North America
13.3.2.2. Prefilled Syringe Fill / Finish Services Marketin Europe
13.3.2.3. Prefilled Syringe Fill / Finish Services Marketin Asia-Pacific
13.3.2.4. Prefilled Syringe Fill / Finish Services MarketLatin America
13.3.2.5. Prefilled Syringe Fill / Finish Services Marketin Middle East and Africa
13.3.3. PrefilledSyringe Fill / Finish Services Market: Distribution by Type of Drug Molecule,2020-2030
13.3.4. PrefilledSyringe Fill / Finish Services Market: Distribution by Therapeutic Area
13.3.5. PrefilledSyringe Fill / Finish Services Market: Distribution by Syringe Barrel Material,2020-2030
13.3.6. PrefilledSyringe Fill / Finish Services Market: Distribution by Number of BarrelChambers, 2020-2030
14. FUTUREGROWTH OPPORTUNITIES
14.1. Chapter Overview
14.2. GrowingInjectable Drugs Pipeline
14.3. Increase inPopularity of Prefilled Syringes
14.4. Rise inPreference for Outsourcing Fill / Finish Activities
14.5. Advances inAseptic Fill / Finish Technologies
14.6. GrowingOpportunities in the Asia-Pacific Region
15. CASE STUDY:PREFILLED SYRINGE MANUFACTURERS
15.1. ChapterOverview
15.2. PrefilledSyringes: List of Available / Under Development Devices
15.2.1. Analysis bySyringe Barrel Material
15.2.2. Analysis byNumber of Barrel Chambers
15.2.3. Analysis byType of Needle System
15.2.4. Analysis byBarrel Volume
15.3. PrefilledSyringes: List of Manufacturers
15.3.1. Analysis byYear of Establishment
15.3.2. Analysis byLocation of Headquarters
16. CONCLUDINGREMARKS
16.1. ChapterOverview
16.2. KeyTakeaways
17. INTERVIEWTRANSCRIPTS
17.1. ChapterOverview
17.2. Bio Elpida
17.2.1. CompanySnapshot
17.2.2. InterviewTranscript: Gilles Devillers, President and Cofounder
17.3. IntasPharmaceuticals
17.3.1. CompanySnapshot
17.3.2. InterviewTranscript: Kirti Maheshwari, Chief Technical Officer
17.4. IDTBiologika
17.4.1. CompanySnapshot
17.4.2. InterviewTranscript: Gregor Kawaletz, Chief Commercial Officer
17.5. Takeda
17.5.1. CompanySnapshot
17.5.2. Interview Transcript:Michael Dekner, Associate Director, Head of Process Sciences Formulation andFill / Finish
17.6. Synegene
17.6.1. CompanySnapshot
17.6.2. InterviewTranscript: Purushottam Singnurkar, Research Director and Head of FormulationDevelopment
17.7. IDEO
17.7.1. CompanySnapshot
17.7.2. InterviewTranscript: Jesse Fourt, Design Director
18. APPENDIX 1:TABULATED DATA
19. APPENDIX 2:LIST OF COMPANIES
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
